Prot #EZH117208: A Phase I Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects with Relapsed/Refractory Diffuse Large B Cell and Transformed Follicular Lymphoma

Project: Research project

StatusActive
Effective start/end date5/28/145/28/20

Funding

  • GlaxoSmithKline LLC (Prot #EZH117208)